Skip to content

Single Session Class to Reduce Opioid Use in Chronic Pain

CompletedNot applicableNCT03950791
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.

Study details

Official title
Single Session Pain Catastrophizing Class: Efficacy & Mechanisms for Reducing Opioid Use Among Chronic Pain Patients
Conditions
Interventions
Sponsor
Stanford University
Collaborators
National Institute on Drug Abuse (NIDA)
Start date
2019-09-23
Primary completion
2024-05-31
Sex
All
Age range
from 18 Years to 80 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18-80 years of age * Diagnosis of chronic non-cancer pain (\> 3 months in duration) * Currently using prescription opioids ≥ 10mg morphine equivalent daily dose (MEDD) for ≥ 3 months; * Ability and willingness to complete study procedures. Exclusion Criteria: * Open litigation regarding a medical condition * Inability to provide informed consent and complete study procedures * Previous experience with cognitive behavioral therapy (CBT) * Active suicidality.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03950791